Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

8.660 +0.280 (+3.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 144,233
Open 8.270
Bid (Size) 7.750 (5)
Ask (Size) 8.950 (15)
Prev. Close 8.380
Today's Range 8.140 - 8.860
52wk Range 3.780 - 14.13
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment
From OptimizeRx Corporation
Via GlobeNewswire

Performance

YTD
+66.22%
+66.22%
1 Month
-8.55%
-8.55%
3 Month
+60.37%
+60.37%
6 Month
+59.19%
+59.19%
1 Year
-5.46%
-5.46%

More News

Read More
Unusual volume stocks in Thursday's session
Via Chartmill
Where OptimizeRx Stands With Analysts
Via Benzinga
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Preview: OptimizeRx's Earnings
Via Benzinga
Top movers in Wednesday's session
Via Chartmill
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million
Via Benzinga
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
From OptimizeRx Corporation
Via GlobeNewswire
Earnings Scheduled For March 12, 2025
Via Benzinga
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OptimizeRx Reports Third Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
From OptimizeRx Corporation
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.